These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 26845021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis.
    Schmohl J, Moebius S, Guenther T, Pepeldjyika E, Seidel CL, Sutanto W, Schuster F, Kraemer D, Salih H, Hartmann A, Tischer J, Ries C, Schmetzer H.
    Anticancer Res; 2021 Aug; 41(8):3891-3898. PubMed ID: 34281851
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 6. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H.
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD.
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [Abstract] [Full Text] [Related]

  • 9. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
    Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K.
    Clin Cancer Res; 2005 Aug 15; 11(16):5708-17. PubMed ID: 16115907
    [Abstract] [Full Text] [Related]

  • 10. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H.
    Eur J Haematol; 2005 Dec 15; 75(6):477-84. PubMed ID: 16313259
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
    Li Q, Kopecky KJ, Mohan A, Willman CL, Appelbaum FR, Weick JK, Issa JP.
    Clin Cancer Res; 1999 May 15; 5(5):1077-84. PubMed ID: 10353741
    [Abstract] [Full Text] [Related]

  • 12. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C, Lenormand B, Bastard C, Boulet D, Lesesve JF, Callat MP, Stamatoullas A, Monconduit M, Tilly H.
    Am J Hematol; 1996 Nov 15; 53(3):175-80. PubMed ID: 8895688
    [Abstract] [Full Text] [Related]

  • 13. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
    Aref S, El-Sherbiny M, Mabed M, Menessy A, El-Refaei M.
    Hematology; 2003 Dec 15; 8(6):385-91. PubMed ID: 14668033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P.
    Am J Clin Pathol; 2003 May 15; 119(5):663-71. PubMed ID: 12760284
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
    Yabushita T, Satake H, Maruoka H, Morita M, Katoh D, Shimomura Y, Yoshioka S, Morimoto T, Ishikawa T.
    Leuk Lymphoma; 2018 Sep 15; 59(9):2144-2151. PubMed ID: 29251166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH, Ball ED, Varki A.
    Exp Hematol; 2006 Jun 15; 34(6):728-35. PubMed ID: 16728277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.